Halt Medical raises $5 million more to treat uterine fibroids
Livermore, Calif.-based Halt Medical tacked an additional $5 million onto a third round of financing — now totaling $17 million — to test a device that can remove uterine fibroids without a hysterectomy. The contribution came from American Capital Strategies, according to VentureWire.
Halt conducted clinical trials in Latin America earlier this year, but expects to kick off a new series of tests in the U.S. by February 2009. Its other investors include William Richter, cofounder of Cerberus Capital Management, and Paul Volcker, former chairman of the Federal Reserve.
See more information on the device here.
Next Story: SolarEdge absorbs $23M to boost solar energy output
Previous Story: Cavium pays $19M for video processor maker W&W
About the Author, Camille Ricketts
Camille is the lead writer for GreenBeat. She came to VentureBeat from Google where she worked on its traditional platforms team, particularly in TV. Before that, she was a reporter for the Wall Street Journal in New York and London. Follow her on Twitter at @camillericketts, and follow VentureBeat on Twitter at @venturebeat.
With GreenBeat 2009, VentureBeat's all-star conference on all things Smart Grid, coming up in November, Camille will be expanding coverage of this exciting space. Stay up to date by following @greenbeat2009 on Twitter or by becoming a fan of the event on Facebook here.